Catheter Precision, Inc.
VTAK · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.12 | 0.48 | 0.78 |
| FCF Yield | -33.39% | -4.91% | -1.95% | -1.86% |
| EV / EBITDA | -2.38 | -27.70 | -51.03 | -57.42 |
| Quality | ||||
| ROIC | -53.38% | -273.73% | -242.34% | -183.66% |
| Gross Margin | 90.00% | 93.21% | -1,050.00% | -6,990.91% |
| Cash Conversion Ratio | 0.56 | 0.29 | 0.84 | 1.10 |
| Growth | ||||
| Revenue 3-Year CAGR | 210.72% | 171.85% | -62.19% | -85.49% |
| Free Cash Flow Growth | 54.88% | 8.37% | 19.02% | 1.70% |
| Safety | ||||
| Net Debt / EBITDA | 0.10 | 0.21 | 0.70 | 0.49 |
| Interest Coverage | -123.55 | 0.00 | -7.40 | -2,926.60 |
| Efficiency | ||||
| Inventory Turnover | 1.27 | 0.68 | 3.07 | 1.58 |
| Cash Conversion Cycle | -1,651.19 | -4,996.87 | -89.76 | 347.94 |